TheraRadar
← Back
Data updated: Jul 17, 2026

CATALENT PHARMA

Generics
Pharmaceuticals

CATALENT PHARMA is a generic drug manufacturer with 1 FDA-approved products.

2025
Since
1
Drugs
-
Trials
0
New Drugs (2yr)

CATALENT PHARMA's Key Drugs

CATALENT PHARMA's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

CATALENT PHARMA's Recent FDA Approvals

New NDA/BLA approvals for CATALENT PHARMA over the last two years — novel drugs only, excluding generics and label supplements.

No recent approvals

CATALENT PHARMA's Therapeutic Areas

Disease areas where CATALENT PHARMA has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.

No indication data

CATALENT PHARMA Pipeline Snapshot

Active clinical trials for CATALENT PHARMA across all therapeutic areas, from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • • Top drug revenue breakdown
  • • Drug-level revenue analysis

Trial Catalysts

  • • Active trial monitoring
  • • Phase 3 readout tracking

Patent Risk

  • • Patent expiration timeline
  • • Revenue at risk analysis

Compare Companies

  • • Side-by-side pipeline analysis
  • • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling